Clearbridge Health (CBH)

Investing ideas

This healthcare stock could be a multibagger as share price plunges to all-time low

SINGAPORE (Mar 10): Phillip Securities Research is reiterating its confidence in healthcare player Clearbridge Health, on the back of the expansion of its regional footprint.

Broker's Calls

Clearbridge Health started at ‘buy’ with 28 cents target by Phillip on growth trajectory

SINGAPORE (Apr 1): Phillip Securities is initiating coverage of Clearbridge Health (CBH) with a “buy”.

IPO

Clearbridge Health associate Biolidics lodges prelim prospectus

SINGAPORE (Nov 26): Biolidics, a cancer diagnostic solutions developer and an associate company of Clearbridge Health, on Friday lodged a preliminary prospectus for a planned initial public offerin

M&A

Clearbridge Health to acquire 65% stake in medical centre in Manila

SINGAPORE (Jan 4): Clearbridge Health’s wholly-owned subsidiary, Clearbridge Health (Philippines), has entered into a conditional share purchase agreement to acquire 65% of the common shares in the

IPO

How clear is Clearbridge Health post-listing outlook?

SINGAPORE (Dec 14): Clearbridge Health (CBH), the healthcare firm which focuses on the delivery of precision medicine, boosts a capable team to lead its expansion across Asia, says Maybank KimEng.

Be informed of the stories that matter